Within the PD patient cohort, there were 59 individuals (12.3%) using acetylsalicylic acid alone, 4 individuals (0.8%) using a combination of acetylsalicylic acid and clopidogrel, 2 individuals (0.4%) using a combination of acetylsalicylic acid and ticagrelor, 1 individual (0.2%) using clopidogrel alone and 1 individual (0.2%) using rivaroxaban (a direct factor X inhibitor). This evidence concerns the gene F10 and Parkinson disease.